T 1556/14 (nab-Paclitaxel combinations/ABRAXIS) of 12.08.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T155614.20190812
- Date of decision
- 12 August 2019
- Case number
- T 1556/14
- Petition for review of
- -
- Application number
- 06735710.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- T 1556/14 nab-Paclitaxel combinations/ABRAXIS 2020-10-15
- Abstracts for this decision
- -
- Application title
- COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY
- Applicant name
- Abraxis BioScience, LLC
- Opponent name
- Generics [UK] Limited
MediGene Aktiengesellschaft - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text and agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.